Abstract
Background
The C-reactive protein/lymphocyte ratio (CLR) is a prognostic biomarker of various diseases. However, its significance in acute pancreatitis (AP) remains unknown. The main aim of this study was to investigate the association between the CLR and disease severity in patients with AP.Methods
This cross-sectional study included 476 AP patients [mild acute pancreatitis (MAP), n =176; moderately severe acute pancreatitis (MSAP) and severe acute pancreatitis (SAP), n =300]. The primary exposure of interest was the baseline CLR. The primary outcome was the incidence of moderate to severe AP. Multivariate logistic regression and restricted cubic spline analyses were performed to evaluate the association between the CLR and the incidence of moderate to severe AP. Receiver operating characteristic (ROC) analysis was conducted to assess the predictive efficacy, sensitivity, and specificity of CLR in predicting the incidence of moderate to severe AP.Results
The mean age of the patients was 44±13.2 years, and 76.5% were male. The distribution of CLR was 31.6 (interquartile range, 4.5, 101.7). Moderate to severe AP occurred in 300 cases (63.0%). After multiple adjustments, CLR was independently associated with the incidence of moderate to severe AP (odds ratio, 1.04; 95% CI: 1.03-1.05; P < 0.001). A nonlinear relationship was found between CLR and the incidence of moderate to severe AP, with a threshold of approximately 45. The effect size and CI below and above the threshold value were 1.061 (1.033-1.089) and 1.014 (0.997-1.031), respectively. The area under the curve (AUC) for CLR was 87.577% (95% CI: 84.443- 90.710%) with an optimal cut-off value of 30.835, resulting in a sensitivity of 73.7% and a specificity of 88.6%.Conclusions
There was a nonlinear relationship with a saturation effect between the CLR and the incidence of moderate to severe AP. The CLR measured within 24 h of admission may serve as a promising biomarker for predicting the emergence of moderate to severe AP, thereby providing a more scientifically grounded basis for preventing such cases. Nonetheless, further research is warranted to validate and strengthen these findings.Full text links
Read article at publisher's site: https://doi.org/10.1097/js9.0000000000001273
Read article for free, from open access legal sources, via Unpaywall: https://journals.lww.com/international-journal-of-surgery/abstract/9900/c_reactive_protein_lymphocyte_ratio_as_a.1145.aspx
References
Articles referenced by this article (26)
Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19.
Int Immunopharmacol, 108781 2022
MED: 35461157
Relationship between the neutrophil-to-lymphocyte ratio in acute pancreatitis and the severity and systemic complications of the disease.
Turk J Gastroenterol, (6):684-691 2018
MED: 30381275
Serum zinc levels and multiple health outcomes: Implications for zinc-based biomaterials.
Bioact Mater, (2):410-422 2020
MED: 32258830
Endoscopic Versus Surgical Step-Up Approach for Infected Necrotizing Pancreatitis (ExTENSION): Long-term Follow-up of a Randomized Trial.
Gastroenterology, (3):712-722.e14 2022
MED: 35580661
Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.
Bioengineered, (1):5138-5148 2021
MED: 34436973
Current Concepts in Severe Acute and Necrotizing Pancreatitis: An Evidence-Based Approach.
Gastroenterology, (7):1994-2007.e3 2019
MED: 30776347
Multifactorial Scores and Biomarkers of Prognosis of Acute Pancreatitis: Applications to Research and Practice.
Int J Mol Sci, (1):E338 2020
MED: 31947993
Red cell distribution width and neutrophil to lymphocyte ratio as predictors of outcomes in acute pancreatitis: A retrospective cohort study.
Int J Surg, 124-127 2018
MED: 29807170
Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer.
Ann Surg Oncol, (10):4017-4025 2020
MED: 32144621
Show 10 more references (10 of 26)
Citations & impact
Impact metrics
Article citations
Assessing the Predictive Utility of the C-Reactive Protein-to-Lymphocyte Ratio for Mortality in Isolated Traumatic Brain Injury: A Single-Center Retrospective Analysis.
Diagnostics (Basel), 14(18):2065, 18 Sep 2024
Cited by: 1 article | PMID: 39335744 | PMCID: PMC11431286
A commentary on 'C-reactive protein/lymphocyte ratio as a prognostic biomarker in acute pancreatitis: A cross-sectional study assessing disease severity'.
Int J Surg, 110(7):4481-4482, 01 Jul 2024
Cited by: 0 articles | PMID: 38537078 | PMCID: PMC11254233
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
[Serum Claudin-5 levels facilitate the early prediction of severe acute pancreatitis: a prospective observational study].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 36(9):930-936, 01 Sep 2024
Cited by: 0 articles | PMID: 39380513
Comparison of the prognostic values of inflammation markers in patients with acute pancreatitis: a retrospective cohort study.
BMJ Open, 7(3):e013206, 27 Mar 2017
Cited by: 40 articles | PMID: 28348184 | PMCID: PMC5372142
Neutrophil-Creatinine Index: A New Prognostic Factor for Severity of Acute Pancreatitis.
Medicina (Kaunas), 60(4):607, 06 Apr 2024
Cited by: 0 articles | PMID: 38674253 | PMCID: PMC11051984
Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage.
Front Neurol, 13:868764, 13 Jun 2022
Cited by: 6 articles | PMID: 35769371 | PMCID: PMC9234282
Review Free full text in Europe PMC